Search - tctmd.com

Displaying 81 - 97 of 97

Sort: Relevancy | Date

News Industry News

REVA Receives CE Mark for Fantom

April 04, 2017

News Industry News

Eurocor announces the completion of the Freeway Stent Study

April 04, 2017

News Conference News ACC 2017

ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience

Michael O'Riordan

March 18, 2017

News Conference News ACC 2017

Live From Washington: ACC 2017, Day One

Shelley Wood

March 17, 2017

News Conference News CRT 2017

Absorb BVS: Better Technique, Better Outcomes? More Data—and More Debate

Michael O'Riordan

February 21, 2017

News Conference News CRT 2017

Higher Mortality Among TAVR Patients With Atrial Fibrillation Treated With Triple Therapy

Michael O'Riordan

February 20, 2017

News Conference News ISET 2017

Bioresorbable Scaffolds for PAD: Does the Strategy Have Legs?

Caitlin E. Cox

February 17, 2017

News Daily News

‘Misalignment’ Exists Between What Concerns Patients and Physicians Most After PCI

Michael O'Riordan

February 13, 2017

Presentation

Beyond Restenosis: Patients’ Preference for Drug-Eluting or Bare-Metal Stents

February 13, 2017

Presentation JIM 2017

EluNIR™The First Elastomeric Drug Eluting Stent (eDES™)

Presenter: Alaide Chieffo

February 09, 2017

News Daily News

10-Year Follow-up of Early DES Shows Steady Risk of Late Events

L.A. McKeown

February 08, 2017

News Daily News

Cobra Stent With Ultrathin Polymer Safe, Effective but Needs Testing in Tougher Patients

Michael O'Riordan

February 03, 2017

News Daily News

Device, Operator, or Lesion: What Affects Long-term Outcomes With Bioresorbable Scaffolds?

Michael O'Riordan

February 02, 2017

News Daily News

TWENTE: Resolute and Xience Stents Show Comparable Outcomes up to 5 Years

Michael O'Riordan

January 20, 2017

Presentation CCVVC 2016

Use of Drug Eluting Stents in the SFA: What are the Current Data, Real World Applications, Upcoming Trials

Presenter: Tyrone Collins

June 15, 2016

News Conference News AHA 2014

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

Yael L. Maxwell

November 16, 2014

News Daily News

FAME Published: FFR Guidance Improves Outcomes in Multivessel Disease

Kim Dalton

January 14, 2009

Advertisement

REVA Receives CE Mark for Fantom

Eurocor announces the completion of the Freeway Stent Study

ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience

Live From Washington: ACC 2017, Day One

Absorb BVS: Better Technique, Better Outcomes? More Data—and More Debate

Higher Mortality Among TAVR Patients With Atrial Fibrillation Treated With Triple Therapy

Bioresorbable Scaffolds for PAD: Does the Strategy Have Legs?

‘Misalignment’ Exists Between What Concerns Patients and Physicians Most After PCI

Beyond Restenosis: Patients’ Preference for Drug-Eluting or Bare-Metal Stents

EluNIR™The First Elastomeric Drug Eluting Stent (eDES™)

10-Year Follow-up of Early DES Shows Steady Risk of Late Events

Cobra Stent With Ultrathin Polymer Safe, Effective but Needs Testing in Tougher Patients

Device, Operator, or Lesion: What Affects Long-term Outcomes With Bioresorbable Scaffolds?

TWENTE: Resolute and Xience Stents Show Comparable Outcomes up to 5 Years

Use of Drug Eluting Stents in the SFA: What are the Current Data, Real World Applications, Upcoming Trials

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

FAME Published: FFR Guidance Improves Outcomes in Multivessel Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content